Was den Menschen zum Menschen macht

Fourteen-Day Rule

6 Min. Lesezeit

🇩🇪 Deutsche Version: 14-Tage-Regel

The fourteen-day rule is an international research-ethics convention: human embryos in vitro may not be cultured for more than 14 days after fertilization — or until the appearance of the primitive streak (around day 14–17 post-fert., corresponding to Carnegie stage 6, the onset of gastrulation).

The rule is normative, not empirical: it sets a research boundary that coincides with a developmental-biological threshold — the point beyond which monozygotic twinning is no longer possible and the question of individuation sharpens.

History

The fourteen-day boundary has been reformulated several times. The most important milestones:

  • 1979 — The Ethics Advisory Board of the US Department of Health, Education, and Welfare first proposes a fourteen-day boundary (report of 4 May 1979).
  • 1984 — Warnock Report (UK): codifies the fourteen-day rule in the context of reproductive medicine; the basis of the British Human Fertilisation and Embryology Act (1990).
  • 2016 — Hyun, Wilkerson and Johnston call in Nature (533:169–171) for a revision, because culture techniques have, for the first time, technically reached the fourteen-day threshold.
  • 2021 — ISSCR Guidelines Update (Lovell-Badge et al., Stem Cell Reports 16(6):1398–1408): relaxes the rule for stem cell-based embryo models (SCBEMs) and permits case-by-case authorizations beyond 14 days, provided a specialized ethical oversight body approves.
  • 2023 — ISSCR Standards for Human Stem Cell Use in Research: codify the pluripotency hierarchy and define the characterization obligations for SCBEM research.
  • 2024 — UK SCBEM Code of Practice: first national regulation specifically for stem cell-based embryo models.
  • 2025 — ISSCR Embryo Models Working Group: Stem cell-based embryo models: The 2021 ISSCR stem cell guidelines revisited (Stem Cell Reports 2025) — discards the distinction “integrated vs. non-integrated” SCBEMs as scientifically untenable; all 3D models with pluripotent components are to be placed under a unified oversight architecture.

Content of the current version

Convention that human embryos in vitro may not be cultured for more than 14 days post-fert. (or until the appearance of the primitive streak). ISSCR Guidelines 2016 (strict), ISSCR Guidelines 2021 (relaxed for SCBEMs and with case-by-case authorization). UK HFEA Code 2024 for SCBEMs.

The current ISSCR version is not the original Warnock consensus: it shifts responsibility from a hard boundary to a discursive oversight exercised by ethically trained committees. This has two consequences:

  1. The fourteen-day threshold is no longer automatically binding in normative terms — it is a default threshold that can be moved in the individual case.
  2. Responsibility for transgressing the boundary no longer lies with the legislator, but with specialized research ethics committees.

Personal-ontological assessment

The fourteen-day rule is underdetermined with respect to the personal-ontological question:

  • Whoever assumes personhood from CS 1 onward cannot accept the fourteen-day rule as a sufficient ethical barrier — it would violate the prohibition on the consumptive use of a human person for 14 days.
  • Whoever assumes personhood only from CS 6 onward (Smith/Brogaard 2003) can read the rule as an operationalizable protection of persons.

Independent of the date, the Personalist Norm demands the recognition of the person as an end in itself — it can be compatible with the fourteen-day rule only if the embryo is not yet a person before the fourteenth day. Whoever holds the substance-ontological thesis that personhood begins at fertilization must therefore criticize the rule as insufficient.

Methodologically orthogonal to this is the tutiorist approach (see Synthetic Embryo Model) — in dubio pro persona — which does not apodictically rule out research on embryos of uncertain status, but demands a markedly stricter burden of justification than the current ISSCR line.

Relation to the relaxation for SCBEMs

For stem cell-based embryo models (SCBEMs), the fourteen-day threshold has been suspended since 2021 — models such as the day-14 post-implantation model of Oldak/Hanna et al. (Nature 2023) may be cultured longer under oversight. The ontological justification of the relaxation runs: SCBEMs are not embryos, but models. This justification is personal-ontologically contested — it hangs on the assumption that the question of the personal status of a sufficiently developed SCBEM has already been decided negatively. Precisely this assumption is rejected in Synthetic Embryo Model.

With the HuDeCA cell atlases (Tyser/Srinivas 2021 for CS 7, Suo 2022 for the fetal immune system, Braun 2023 for the first trimester), the transcriptomic comparability of SCBEMs with in vivo embryos becomes operationalizable for the first time. With this, the ethical discussion shifts from the morphological question “Does the model look like an embryo?” to the empirically precise question “Which single-cell signature of a natural stage does it recapitulate?” — and precisely this shift makes the current fourteen-day relaxation more in need of explanation, not less.

Sources: Generated by querying the Personhood ontology.

Further sources:

  • Ethics Advisory Board, U.S. Department of Health, Education, and Welfare (1979): Report and Conclusions: HEW Support of Research Involving Human In Vitro Fertilization and Embryo Transfer, 4 May 1979. (First international source of a fourteen-day recommendation.)
  • Warnock, Mary (1984): Report of the Committee of Inquiry into Human Fertilisation and Embryology. London: HMSO. (Canonical first codification of the fourteen-day rule; basis of the UK Human Fertilisation and Embryology Act 1990.)
  • Hyun, Insoo; Wilkerson, Amy & Johnston, Josephine (2016): Embryology policy: Revisit the 14-day rule. Nature 533: 169–171. DOI: 10.1038/533169a.
  • Lovell-Badge, R.; Anthony, E.; Barker, R. A. et al. (2021): ISSCR Guidelines for Stem Cell Research and Clinical Translation: The 2021 update. Stem Cell Reports 16(6): 1398–1408. DOI: 10.1016/j.stemcr.2021.05.012.
  • Clark, A. T.; Brivanlou, A.; Fu, J. et al. (2021): Human embryo research, stem cell-derived embryo models and in vitro gametogenesis: Considerations leading to the revised ISSCR guidelines. Stem Cell Reports 16(6): 1416–1424. DOI: 10.1016/j.stemcr.2021.05.008.
  • ISSCR (2023): Standards for Human Stem Cell Use in Research. International Society for Stem Cell Research, approved April 2023, published June 2023.
  • ISSCR Embryo Models Working Group (2025): Stem cell-based embryo models: The 2021 ISSCR stem cell guidelines revisited. Stem Cell Reports 2025.
  • Smith, Barry & Brogaard, Berit (2003): Sixteen Days. Journal of Medicine and Philosophy 28(1): 45–78.
  • Damschen, Gregor; Gómez-Lobo, Alfonso & Schönecker, Dieter (2006): Sixteen Days? A Reply to B. Smith and B. Brogaard on the Beginning of Human Individuals. Journal of Medicine and Philosophy 31(2): 165–175.
  • Tyser, R. C. V.; Mahammadov, E.; Nakanoh, S.; Vallier, L.; Scialdone, A. & Srinivas, S. (2021): Single-cell transcriptomic characterization of a gastrulating human embryo. Nature 600(7888): 285–289. DOI: 10.1038/s41586-021-04158-y. (HuDeCA reference for CS 7, basis of the SCBEM benchmarking discussion.)
  • Suo, C.; Dann, E.; Goh, I.; … Haniffa, M.; Teichmann, S. A. et al. (2022): Mapping the developing human immune system across organs. Science 376(6597): eabo0510. DOI: 10.1126/science.abo0510.
  • Braun, E.; Danan-Leon, M.; Hochgerner, H.; … & Linnarsson, S. (2023): Comprehensive cell atlas of the first-trimester developing human brain. Science 382(6667): eadf1226. DOI: 10.1126/science.adf1226.

See also

Graphansicht

Backlinks